» Articles » PMID: 12692142

Active Hexose Correlated Compound Enhances Resistance to Klebsiella Pneumoniae Infection in Mice in the Hindlimb-unloading Model of Spaceflight Conditions

Overview
Date 2003 Apr 15
PMID 12692142
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have demonstrated that resistance to infection is decreased in Swiss Webster female mice maintained in the hindlimb-unloading model (Aviles H, Belay T, Fountain K, Vance M, and Sonnenfeld G. J Appl Physiol 95: 73-80, 2003; Belay T, Aviles H, Vance M, Fountain K, and Sonnenfeld G. J Allergy Clin Immunol 110: 262-268, 2002). This is a model of some of the aspects of spaceflight conditions, including lack of load bearing on hindlimbs and a fluid shift to the head. Active hexose correlated compound (AHCC), extracted from Basidiomycete mushrooms, has been shown to induce enhancement of immune responses, including enhanced natural killer activity. In the present study, AHCC was orally administered to mice to determine whether the treatment could decrease immunosuppression and mortality of mice maintained in the hindlimb-unloaded model and infected with Klebsiella pneumoniae. The results of the present study showed that administration of AHCC by gavage for 1 wk (1 g/kg body wt) before suspension and throughout the 10-day suspension period yielded significant beneficial effects for the hindlimb-unloaded group, including 1). decreased mortality, 2). increased time to death, and 3). increased ability to clear bacteria. The results suggest that AHCC can decrease the deleterious effects of the hindlimb-unloading model on immunity and resistance to infection.

Citing Articles

Hepatoprotection of a Standardized Extract of Cultured Mycelia against Liver Injury Induced by Ischemia-Reperfusion and Partial Hepatectomy.

Nakatake R, Okuyama T, Ishizaki M, Yanagida H, Kitade H, Yoshizawa K Nutrients. 2024; 16(2).

PMID: 38257149 PMC: 10820669. DOI: 10.3390/nu16020256.


Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study.

Hashimoto D, Satoi S, Ishikawa H, Kodera Y, Kamei K, Hirano S Trials. 2022; 23(1):135.

PMID: 35151367 PMC: 8841079. DOI: 10.1186/s13063-021-05934-x.


The Effects of AHCC®, a Standardized Extract of Cultured Mycelia, on Natural Killer and T Cells in Health and Disease: Reviews on Human and Animal Studies.

Shin M, Park H, Maeda T, Nishioka H, Fujii H, Kang I J Immunol Res. 2020; 2019:3758576.

PMID: 31930148 PMC: 6942843. DOI: 10.1155/2019/3758576.


Practical Application of "About Herbs" Website: Herbs and Dietary Supplement Use in Oncology Settings.

Hou Y, Deng G, Mao J Cancer J. 2019; 25(5):357-366.

PMID: 31567464 PMC: 6777855. DOI: 10.1097/PPO.0000000000000403.


Bioactive Immunomodulatory Compounds: A Novel Combinatorial Strategy for Integrated Medicine in Oncology? BAIC Exposure in Cancer Cells.

Corradetti B, Vaiasicca S, Mantovani M, Virgili E, Bonucci M, Hammarberg Ferri I Integr Cancer Ther. 2019; 18:1534735419866908.

PMID: 31416372 PMC: 6699000. DOI: 10.1177/1534735419866908.